Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- July 2020
has subject area
- Anti-Inflammatory Agents, Non-Steroidal (MeSH)
- Betacoronavirus (MeSH)
- COVID-19 (MeSH)
- Canada (MeSH)
- Coronavirus Infections (MeSH)
- Dermatology & Venereal Diseases (Science Metrix)
- Humans (MeSH)
- Medication Adherence (MeSH)
- Pandemics (MeSH)
- Pneumonia, Viral (MeSH)
- Psoriasis (MeSH)
- Retrospective Studies (MeSH)
- SARS-CoV-2 (MeSH)
- Thalidomide (MeSH)